Showing results (31-40 of 190) with videos related to
Sort By:
Pageof 19
Dermatologic Clinics|January 1, 1993
The staphylococci. Importance of their control in the management of skin diseaseR E Williams, R M MacKieThe British Journal of Dermatology|August 1, 1986
An assessment of the diagnostic value of the monoclonal antibodies Leu 8, OKT9, OKT10 and Ki67 in cutaneous lymphocytic infiltratesM L Turbitt, R M MackieJournal of Cutaneous Pathology|April 1, 1981
Studies in cutaneous immunofluorescence. II. Histological and direct immunofluorescence observations in clinically normal skin of patients with rheumatoid arthritisH M Nelson, R M MacKieThe British Journal of Dermatology|March 1, 1980
The use of the Psorilux 3050A machine in the management of psoriasis of the hands and feetH M Nelson, R M MacKieClinical Allergy|July 1, 1981
A double-blind trial of the H2 receptor antagonist cimetidine, and the H1 receptor antagonist promethazine hydrochloride in the treatment of atopic dermatitisI S Foulds, R M MacKieThe British Journal of Dermatology|April 1, 1990
Serum lipid elevation during isotretinoin therapy for acne in the west of ScotlandB R Walker, R M MacKieThe British Journal of Dermatology|May 31, 2008
An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosisJ Einwachter-Thompson, R M MacKieBMJ (Clinical Research Ed.)|May 4, 1996
Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic statusR M MacKie, D J HoleThe British Journal of Dermatology|May 1, 1981
Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesionsM L Turbitt, R M MackieBritish Medical Journal (Clinical Research Ed.)|April 12, 1986
Reasons for poor prognosis in British patients with cutaneous malignant melanomaV R Doherty, R M MacKiePageof 19